Foundry Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-200,778
| Closed | -$14.7M | – | 305 |
|
|
2024
Q1 | $14.7M | Buy |
200,778
+6,355
| +3% | +$489K | 0.78% | 35 |
|
|
2023
Q4 | $15.8M | Sell |
194,423
-24,069
| -11% | -$1.87M | 0.95% | 28 |
|
|
2023
Q3 | $16.4M | Sell |
218,492
-1,329
| -0.6% | -$102K | 1.02% | 27 |
|
|
2023
Q2 | $16.9M | Sell |
219,821
-90,340
| -29% | -$7.21M | 1.04% | 25 |
|
|
2023
Q1 | $25.7M | Sell |
310,161
-31,258
| -9% | -$2.59M | 1.62% | 4 |
|
|
2022
Q4 | $29.3M | Sell |
341,419
-4,536
| -1% | -$359K | 1.62% | 11 |
|
|
2022
Q3 | $21.3M | Buy |
+345,955
| New | +$21.8M | 1.34% | 16 |
|
|
2020
Q4 | – | Sell |
-221,377
| Closed | -$14M | – | 427 |
|
|
2020
Q3 | $14M | Buy |
221,377
+55,911
| +34% | +$3.88M | 0.68% | 40 |
|
|
2020
Q2 | $12.7M | Sell |
165,466
-13,736
| -8% | -$1.05M | 0.62% | 44 |
|
|
2020
Q1 | $13.4M | Buy |
179,202
+910
| +0.5% | +$62.9K | 0.76% | 32 |
|
|
2019
Q4 | $11.6M | Sell |
178,292
-106,767
| -37% | -$6.95M | 0.44% | 87 |
|
|
2019
Q3 | $18.1M | Buy |
285,059
+176,990
| +164% | +$11.6M | 0.75% | 28 |
|
|
2019
Q2 | $7.3M | Buy |
+108,069
| New | +$7.11M | 0.29% | 117 |
|
|
2018
Q1 | – | Sell |
-3,606
| Closed | -$258K | – | 402 |
|
|
2017
Q4 | $258K | Sell |
3,606
-158,795
| -98% | -$12.1M | 0.01% | 371 |
|
|
2017
Q3 | $13.2M | Buy |
162,401
+48,545
| +43% | +$3.71M | 0.53% | 51 |
|
|
2017
Q2 | $8.06M | Buy |
113,856
+108,052
| +1,862% | +$7.19M | 0.33% | 107 |
|
|
2017
Q1 | $394K | Sell |
5,804
-2,118
| -27% | -$149K | 0.02% | 390 |
|
|
2016
Q4 | $567K | Sell |
7,922
-13,630
| -63% | -$1.01M | 0.02% | 372 |
|
|
2016
Q3 | $1.71M | Sell |
21,552
-6,058
| -22% | -$492K | 0.09% | 274 |
|
|
2016
Q2 | $2.3M | Sell |
27,610
-9,400
| -25% | -$834K | 0.13% | 247 |
|
|
2016
Q1 | $3.4M | Sell |
37,010
-52,233
| -59% | -$4.71M | 0.34% | 82 |
|
|
2015
Q4 | $9.03M | Buy |
89,243
+6,627
| +8% | +$690K | 0.75% | 36 |
|
|
2015
Q3 | $8.11M | Sell |
82,616
-1,585
| -2% | -$176K | 0.71% | 41 |
|
|
2015
Q2 | $9.86M | Buy |
84,201
+32,006
| +61% | +$3.5M | 0.79% | 35 |
|
|
2015
Q1 | $5.12M | Buy |
+52,195
| New | +$5.3M | 0.43% | 90 |
|
|
2014
Q4 | – | Sell |
-134,065
| Closed | -$14.3M | – | 255 |
|
|
2014
Q3 | $14.3M | Sell |
134,065
-59,425
| -31% | -$5.82M | 1.32% | 10 |
|
|
2014
Q2 | $16M | Buy |
193,490
+18,895
| +11% | +$1.47M | 1.49% | 7 |
|
|
2014
Q1 | $12.4M | Sell |
174,595
-54,219
| -24% | -$4.25M | 1.16% | 12 |
|
|
2013
Q4 | $17.2M | Buy |
+228,814
| New | +$15.9M | 1.54% | 5 |
|
Other funds holding GILD
Foundry Partners's GILD Position: Q2 2024 in Review
Foundry Partners sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 200,778 shares — an estimated $14.7M sold.
Foundry Partners first reported a position in GILD in Q4 2013 and held it in 29 quarters. The position peaked at $29.3M in Q4 2022. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.
- Foundry Partners reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
- Foundry Partners sold 200,778 Gilead Sciences shares in Q2 2024, an estimated $14.7M.
- Foundry Partners first reported a position in Gilead Sciences in Q4 2013 and held it in 29 quarters.
- Foundry Partners's Gilead Sciences position peaked at $29.3M in Q4 2022.
- 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.
Based on Foundry Partners's 13F filing for Q2 2024, filed 5 Aug 2024.